Business Context and Reporting Period
Aveanna Healthcare Holdings, Inc. (AVAH) filed a Form 8-K on March 9, 2026, reporting a significant corporate event. The filing details an agreement entered into on March 9, 2026, by Pediatric Services of America, LLC, a wholly-owned subsidiary of the Company, to acquire Family First Holding, LLC.
Key Financial Metrics
This filing is a Current Report (8-K) and does not contain periodic financial statements. Consequently, specific metrics such as revenue, profit, cash flow, margins, debt, and liquidity for the reporting period are not provided in this document.
- Transaction Value: $175.5 million (cash purchase price).
- Funding Source: Combination of cash on hand and existing short-term credit facility borrowing.
Material Changes
The primary material change is the execution of an Equity Interest Purchase Agreement to acquire all issued and outstanding membership interests of Family First Holding, LLC. The transaction is subject to customary adjustments for working capital and other items.
Outlook, Risks, and Contingencies
Closing Timeline: The transaction is expected to close in the second fiscal quarter of 2026.
Closing Conditions: The deal is contingent upon several factors, including:
- Accuracy of representations and warranties.
- Compliance with pre-closing covenants.
- Expiration or termination of the Hart-Scott-Rodino Antitrust waiting period.
- Absence of laws or governmental orders preventing the transaction.
- No material adverse effect occurring since the signing date.
Risk Mitigation: The Buyer has obtained a representation and warranty insurance policy to cover certain breaches by the Sellers, subject to exclusions and deductibles.
Investor Verification Checklist
- Verify the final closing date and whether the transaction closes in Q2 2026 as expected.
- Confirm the final purchase price after working capital and customary adjustments.
- Monitor the impact of the transaction on the Company's liquidity and short-term credit facility utilization.
- Review the press release (Exhibit 99.1) for additional strategic rationale not detailed in the 8-K.
- Check for any regulatory approvals required under the Hart-Scott-Rodino Act.